Founder And Managing Director
CurrentOn November 1, 2013, Biomark Capital Partners effected a transfer of the portfolio and core team of Burrill Capital Fund IV(BCF IV) from Burrill & Company. Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. We target companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. We share the drive and vision of our portfolio companies to collaborate with them in accelerating growth and building successful business ventures.